You are here: Industry Insights > Schrödinger

News List

BMS inks drug discovery deal with Schrödinger pharmatimes
November 25, 2020
Bristol Myers Squibb will pay $55m upfront to American life sciences company Schrödinger to access its drug discovery platform.
Twist Bioscience announces strategic collaboration with Schrödinger for drug discovery pharmaceutical-business-review
January 19, 2020
Twist Bioscience, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced a collaboration with Schrödinger, a company focused on transforming the way therapeutics are discovered with
Schrödinger, Bayer collaborate to co-develop de novo design technology to accelerate drug discovery americanpharmaceuticalreview
January 13, 2020
Schrödinger and Bayer announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs.
Schrödinger, AstraZeneca join hands to accelerate drug dicovery biospectrumasia
September 05, 2019
Schrödinger’s platform will be used by AstraZeneca’s medicinal and computational chemists
Schrödinger Expands Drug Discovery Partnership with Morphic Therapeutic americanpharmaceuticalreview
August 14, 2019
chrödinger announced an expansion of its computational design collaboration with Morphic Therapeutic, a biotechnology company focused on developing a new class of oral small-molecule integrin-targeted therapeutics that Schrödinger co-founded with ...
Schrödinger raises $110m to develop drug discovery platform pharmaceutical-technology
May 22, 2019
Schrödinger has raised $110m during a funding round to develop its computational platform, which combines physics-based molecular simulations and machine learning for the exploration of chemical space.
Schrödinger and SPARC announce collaboration to accelerate neurodegeneration drug development program expressbpd
December 04, 2018
Collaboration brings together Schrödingers in silico discovery capabilities with SPARC’s novel insights into CNS pathways to speed drug development
Schrödinger, WuXi AppTec Enter Drug Discovery Tie-up contractpharma
November 12, 2018
Schrödinger, WuXi AppTec Enter Drug Discovery Tie-up